1. Cohorts Resec1, Resec2, Resec3, Resec4, TCIA consisted of patients who had undergone resection;

2. Cohorts IMU1, IMU2, IMU3 consisted of patients who had received immunotherapy;

3. Cohorts Chem1, Chem2 consisted of patients who had received platinum-based chemotherapy;

4. Cohorts TKI1, TKI2 consisted of patients who had received EGFR-TKI targeted therapy.  
